What is Nektar Therapeutics's shares (basic)?

Nektar Therapeutics (NKTR) reported shares (basic) of 24.7M in Q1 2026.

How has Nektar Therapeutics's shares (basic) changed year-over-year?

Nektar Therapeutics's shares (basic) increased by 75.9% year-over-year, from 14.1M to 24.7M.

What is the long-term trend for Nektar Therapeutics's shares (basic)?

Over 4 years (2021 to 2025), Nektar Therapeutics's shares (basic) has grown at a -45.6% compound annual growth rate (CAGR), from 731.5M to 64M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Nektar Therapeutics NKTR Shares (Basic)

Shares (Basic) at other companies

AmgenAMGN

540M+0.4%

Regeneron PharmaceuticalsREGN

104M-2.5%

ImmunityBio, Inc.IBRX

1B+20.4%

Apogee Therapeutics, Inc.APGE

69.7M+19.7%

ImmunomeIMNM

113.1M+42.5%

Vera TherapeuticsVERA

71.5M+12.3%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's shares (basic)?: Nektar Therapeutics (NKTR) reported shares (basic) of 24.7M in Q1 2026.
How has Nektar Therapeutics's shares (basic) changed year-over-year?: Nektar Therapeutics's shares (basic) increased by 75.9% year-over-year, from 14.1M to 24.7M.
What is the long-term trend for Nektar Therapeutics's shares (basic)?: Over 4 years (2021 to 2025), Nektar Therapeutics's shares (basic) has grown at a -45.6% compound annual growth rate (CAGR), from 731.5M to 64M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.